Curia (RNA/Advanced)

Albany, NY · Albuquerque, NM
mRNA Oligonucleotide Biologics
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
79.2
Signal Score
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (15) ○ MHRA GMP

Quick Facts: Curia (RNA/Advanced)

Signal Score
79.2/100 (as of 2026-04-29)
Quality Compliance
99.4/100
Headquarters
Albany, NY · Albuquerque, NM
Modalities
mRNA, Oligonucleotide, Biologics
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Curia (RNA/Advanced)

Formerly AMRI. Expanding into RNA therapeutics CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 99.4
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-12-02)
EMA GMP Certificates15 on record
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 63.0
2 manufacturing sites
Sites: Albany, NY, Albuquerque, NM
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
2 manufacturing sites

FDA Inspection History

2025-12
2025-05
NAI VAI OAI
Date Site Type Observations Classification
2025-12-02 Springfield, Missouri Drug Quality Assurance No No Action Indicated (NAI)
2025-05-09 Albany, New York Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved May 20, 2026

EMA GMP Compliance 15 certificates

2026-02
2026-02
2025-11
2025-04
2025-03
2024-12
2024-06
2023-05
2023-02
2023-02
2023-02
2023-02
2023-02
2023-02
2023-02
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
411/26 Curia Spain S.A.U. Spain 2026-02-13 COMPLIANT
10350-004/26 Curia Spain S.A.U. Spain 2026-02-13 COMPLIANT
25MPP072HFR01 Curia France S.A.S. France 2025-11-27 COMPLIANT
IT-API/120/H/2025 Curia Italy S.r.l. Italy 2025-04-11 COMPLIANT
25MPP015HFR01 Curia France S.A.S. France 2025-03-28 COMPLIANT
IT-API/29/H/2025 Curia Italy S.r.l. Italy 2024-12-05 COMPLIANT
24MPP026HFR01 Curia France S.A.S. France 2024-06-07 COMPLIANT
IT-API/20/H/2024 Curia Italy S.r.l. Italy 2023-05-25 COMPLIANT
M00611-03/23/02 Curia Spain S.A.U. Spain 2023-02-27 COMPLIANT
M00611-02/23/01 Curia Spain S.A.U. Spain 2023-02-27 COMPLIANT
10350-004/23 Curia Spain S.A.U. Spain 2023-02-27 COMPLIANT
M00611-01/23 Curia Spain S.A.U. Spain 2023-02-27 COMPLIANT
M00611-03/23 Curia Spain S.A.U. Spain 2023-02-27 COMPLIANT
M00611-02/23 Curia Spain S.A.U. Spain 2023-02-27 COMPLIANT
IT-API/265/H/2023 Curia Italy S.r.l. Italy 2023-02-24 COMPLIANT
Source: EMA EudraGMDP · Retrieved May 20, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
mRNA CDMOs → Oligonucleotide CDMOs → Biologics CDMOs →

Similar CDMOs

Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 85.6
Oligonucleotide, Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy